RT Journal Article
SR Electronic
T1 Bridging the gaps in test interpretation of SARS-CoV-2 through Bayesian network modelling
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.30.20241232
DO 10.1101/2020.11.30.20241232
A1 Yue Wu
A1 David Foley
A1 Jessica Ramsay
A1 Owen Woodberry
A1 Steven Mascaro
A1 Ann E Nicholson
A1 Tom Snelling
YR 2020
UL http://medrxiv.org/content/early/2020/12/02/2020.11.30.20241232.abstract
AB Background In the absence of an established gold standard, an understanding of the testing cycle from individual exposure to test outcome report is required to guide the correct interpretation of SARS-CoV-2 reverse transcriptase real-time polymerase chain reaction (RT-PCR) results and optimise the testing processes. Bayesian network (BN) models have been used within healthcare to bring clarity to complex problems. We use this modelling approach to construct a comprehensive framework for understanding the real world predictive value of individual RT-PCR results.Methods We elicited knowledge from domain experts to describe the test process from viral exposure to interpretation of the laboratory test, through a facilitated group workshop. A preliminary model was derived based on the elicited knowledge, then subsequently refined, parameterised and validated with a second workshop and one-on-one discussions.Results Causal relationships elicited describe the interactions of multiple variables and their impact on a RT-PCR result. Some interactions are infrequently observable and accounted for across the testing cycle such as pre-testing factors, sample collector experience and RT-PCR platform. By setting the input variables as ‘evidence’ for a given subject and preliminary parameterisation, three scenarios were simulated to demonstrate potential uses of the model.Conclusions The core value of this model is a deep understanding of the total testing cycle, bridging the gap between a person’s true infection status and their test outcome. This model can be adapted to different settings, testing modalities and pathogens, adding much needed nuance to the interpretations of results.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding for this project has been provided by the Digital Health Cooperative Research Centre and the Snow Medical Research Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDetailed conditional probability tables can be accessed via testing_v7.6_params.xdsl on the OSF platform, which will also include any future updates. https://osf.io/x5c4u/?view_only=afbdfb3e22c2406cad1ae142a3e5a3b2